By 2031, regulators approve adaptive prostheses as bounded design systems, allowing clinical agents to reshape each device as its wearer grows or their gait changes.
These references were saved as background for this fictional scenario.
A prosthesis is no longer a finished object replaced every few years. It becomes a continuously revised system whose geometry adapts within clinician-approved constraints. Device makers earn revenue from validated design rules, while local clinics manufacture updated parts near the wearer and preserve the option of restoring an earlier shape.
At 6:25 a.m. in a Busan apartment, twelve-year-old Ji-an clips an ankle component printed overnight into her prosthesis. Her clinician has already approved the agent's proposed change, prompted by a limp recorded on her walk home the previous day. Before leaving for school, Ji-an tests the new part in the stairwell.
A vendor could narrow the permitted design space, extract intimate movement data, or disable older components through an update. The optimistic outcome depends on independent records, interchangeable parts, offline controls, and a permanent right to manual fitting.